an alumni reflection on liu-
TRANSCRIPT
2
Table of Contents
Pharmacy Practice
The
Pharmacy
Newsletter
THE SPOTLIGHT: Clubs & Organ-
izations
By Dominic Regalbuto, B.S., PharmD Candidate
2017
The world of medicine is continuously in flux. New discov-
eries in science and medicine mean constant turnover in in-
formation. Although these transformations often occur on a
macro level, it is important to be involved with small scale
organizations to disseminate information to the community.
These organizations are often involved in events that im-
prove the well-being of the community. They focus on rais-
ing awareness about health issues, improving health literacy,
and providing health services to the public. Without these
organizations, we would be hard-pressed to deliver the
guidelines of large associations in a personable manner.
In this newsletter, one can find articles about the particular
efforts of clubs and organizations from our own campus that
reach out to the community. This includes a review of recent
events such as the iGIVE Spelling Bee, the SNPhA vaccina-
tion awareness event, a multi-organizational health fair col-
laboration, and many other organizational updates. You can
also read about new happenings affecting the field of health.
All this and more can be read in the February edition of
TPN.
Beta blockers in COPD patients 6
Health Sciences
Ebola Epidemic 3
Clubs and Organizations
iGIVE Spelling Bee 4
AMCP 5
SNPhA 8
NJPhA 8
ACCP 9
JPS 9
Rho Chi 10
APhA 10
LEGAL NOTICE
This newsletter is run by TPN and in no way
represents the views of Long Island Univer-
sity or LIU-Pharmacy. All of the views re-
flected within are solely the views of this or-
ganization and are not representative of
Long Island University or LIU-Pharmacy.
The Fear of an Epidemic By Hazel Joseph and Anu Thadavila,PharmD Candidates 2018
Last March was a historically devastating month for the Ebo-
la virus. According to the World Health Organization's article,
“Ebola Response Roadmap Situation Report,” in just 8
months, Ebola has infected a reported 13,042 people and
claimed the lives of a reported 4,818. The virus spread quick-
ly throughout several countries in Western Africa such as Li-
beria and Sierra Leone. The virus then travelled to other
countries such as Spain and the United States. Though this
disease has hit so close to home, not many were informed on
how to handle such a debilitating illness with deceivingly sim-
ilar symptoms to the common cold and influenza.
There are two ways the disease can be transmitted between
humans. One is through direct contact, in which an infected
individual’s blood or other bodily fluids come in contact with
the broken skin or mucous membranes of an unaffected in-
dividual. It can also be spread through surfaces and materials
such as bedding and clothing, that are contaminated with
bodily fluids. An infected person does not exhibit symptoms
until the incubation period of 2 to 21 days is over. While an
infected person is asymptomatic, the virus is not contagious.
The initial symptoms of this disease are fever, fatigue, muscle
pain, headache and sore throat. These symptoms are also
present in the common cold and influenza. The more severe
symptoms that may develop later include vomiting, diarrhea,
rash, as well as internal and external bleeding. People afflicted
with Ebola are also found to have low white blood cell and
platelet counts, impaired kidney function, and elevated liver
enzymes.
As LIU students, we should follow the safety precautions
posted by the Centers for Disease Control and Preventions at
www.cdc.gov. Because of how unpredictable and detrimental
this disease is, we need to be very careful in how we interact
with individuals who may have this virus. In the case of an
3
outbreak, we should be very cautious when dealing with
sick individuals at home, work, or school. While taking
care of those who may be ill, always make sure to put on
personal protective equipment and avoid contact with
bodily fluids. Please practice proper hygiene and wash
with soap or an alcohol-based hand sanitizer to rid your
skin of the virus. These safety measures are good to fol-
low in general. As the saying goes, "it is always better to
be safe than sorry."
Sandra Cristina Felix graduated from Long Island Uni-
versity in 2011. She currently works as a staff pharmacist
for CVS Pharmacy. When asked about how LIU helped
her in preparing for her future she said, "I think the reci-
tations helped us to apply what we learned in class to real
life situations. Many times, it would help clear up certain
concepts that we were learning in class because you were
able to see how it would work in a real patient case." San-
dra is one of the few pharmacists I know who remem-
bers every detail about her time at LIU, from the profes-
sors to her fellow classmates. All you have to do is de-
scribe professors and she will be able to tell you what
they taught and how they taught it. I asked Sandra if she
remembered one specific professor who she felt really
influenced her. After giving it some thought she said, "I
think Dr. Nogid was really tough but a very good teacher.
She taught kinetics and it was the hardest class I ever
took. To be honest, I didn't even do well in her class,
but she really knew what she was doing. It's always nice
to see that your professor is enjoying what they are teach-
ing." Recently, many new graduates are getting burned
out in retail pharmacy due to the overwhelming workload
and constant pressure from corporate. When I asked
Sandra about how she felt and whether or not she had
An Alumni Reflection on LIU-
Pharmacy
By Karishma Syed, B.S., PharmD Candidate
2017
Continued on page 5….
Pharmacy Updates The Food & Drug Admin-
istration’s proposed amend-
ment in prescription product
labelling
The FDA has proposed amend-
ing its prescription drug and
biological product labelling to
allow public electronic distribu-
tion of the prescribing infor-
mation. Under the new proposal,
paper formatted prescribing
information will be replaced by
an electronic version– a switch
that would ensure up-to-date
information on the safety and
effectiveness of drug and biolog-
ical products.
Under the recently passed New
York State I-STOP bill, elec-
tronic prescribing will be man-
dated for all New York State
prescriptions. Obligation to pre-
scribers and pharmacies to pre-
scribe and receive prescriptions
electronically will take effect
come March 27, 2015. The land-
mark passage of I-STOP grants
overhaul of prescription distri-
bution and monitoring, allowing
modernization and accountabil-
ity in the prescribing and dis-
pensing of controlled substances.
The details for electronic trans-
mittance of prescriptions can be
found in New York State’s Of-
fice of the Profession’s web-
site: http://www.op.nysed.gov/
prof/pharm/
pharmelectrans.htm
4
iGIVE Spelling Bee: Faculty vs. Students Showdown By Nubriel Hernandez, B.A. and Tavajay Campbell, B.A., PharmD Candidates 2017
In an effort to unite the student body in service to the in-
ternational community, a new student organization,
iGIVE (Initiation of Giving Internationally through Vol-
unteer Experiences), was created. Building upon the
foundation of iLEAP, Dr. Suzanna Gim empowered stu-
dents who were not only willing to travel abroad to serve
people in need, but also possessed the drive to collaborate
with students from various fields. In the past, pharmacy
and nursing students have travelled the globe to places
such as Costa Rica and Sierra Leone providing medical
supplies, knowledge, and assistance to communities
worldwide. The group believes that it is through the com-
bination of skills and the desire to help those in need that produces the greatest impact in any
location. Because of the vast economic burden of this charity, fundraisers such as iGIVE’s
Medical Spelling Bee are conducted to raise the money for the supplies used on these trips.
Eager to end the monotonous, but admittedly delicious cycle of bake sales, iGIVE held a medi-
cal spelling bee on October 14th, 2014 with the winner receiving a $50 gift card to Nordstrom.
The goal of this event was to raise funds for last year’s trip to Guatemala. Faculty and students
alike participated in the event that featured multiple rounds of competition culminating in the
final round of a professor versus a student. Faculty participants included Mr. Bova, Mr. Gonza-
lez, Dr. Bellantone, Dr. Kish, Dr. Wong, and Dr. Zerilli. Student participants included P4’s
Umar Amtiaz, Danay Ashley, Kevin Morales, Julie Samuel and P6’s Robin Singer, Dana He,
Scott Guzik, Patricia Flannery and Pakiki Emmanuel. The rules stated that professors compete
against professors and students against students until the final round. Competitors were allowed
to ask for the indications of medications and for repeated pronunciations. If a participant mis-
spelled the word then he or she would be eliminated. However, in the semifinal round the next
participant would need to spell the word correctly in order to advance to the final round. After
each round, the level of difficulty increased. There were a total of five rounds and after three of
those rounds, the two professors left were Dr. Wong and Dr. Zerilli.
Student and faculty participants and organizers from the iGIVE spelling bee
On October 27th, the Academy of Managed Care
Pharmacy (AMCP) of LIU-Pharmacy along with CVS
Health Partnership hosted a special Dean’s Hour and
Horizons in Pharmacy Lecture Series Program with
guest speaker Edith Rosato, RPh, IOM, CEO of AMCP, Chair of the Board of Trustees
for the AMCP Foundation.
Ms. Rosato, a pharmacist with extensive experience in the field of health care, shared a
brief history of her personal career and how she achieved her present position at AMCP.
Ms. Rosato highlighted some key qualities that are inherent in a successful leader such as
having a passion for the profession, not being afraid to ask questions, and the ability to
work in a team. She also shared the vision for pharmacy’s ever-changing future from the
perspective of AMCP.
Over the course of the 2014-2015 academic year, our LIU-Pharmacy AMCP chapter will
host a variety of programs under the guidance Dr. Jun-Yen Yeh, our newly appointed fac-
ulty advisor and professor of pharmacoeconomics. Dr. Yeh has been instrumental in steer-
ing our chapter’s course. Thanks to him, we will be participating in the AMCP Founda-
tion’s Annual Pharmacy and Therapeutics Competition, which will expose our members to
the processes that are used in the development of effective formulary systems. The experi-
ence will also provide students with the opportunity to enhance their analytical and re-
search skills. In addition, our chapter plans on participating in community outreach pro-
grams, hosting events, and encouraging the vision and fundamental values of AMCP.
Continued from Page 3
any regrets about choosing pharma-
cy as a career path, she said, "I en-
joy what I do and I'm happy with
retail. I think it's important to have
a pharmacist who still cares about
helping patients and not just about
pleasing corporate. Don't get me
wrong, sometimes it gets really cra-
zy and I want to go into a corner to
cry, but you get over it. You have
to remember why you’re here. A lot
of people do retail for the money or
to move up in the company. I don't
want to move up, I'm happy where
I am. I think this is where I will be
most useful to patients who can't
visit their doctor every time they
have a problem. It is rewarding
when you see them getting better
through the years and when they
thank you for being a part of that
journey. Personally, it still makes
me feel good."
Sanda Cristina Felix, PharmD
5
The final two student competitors were Kevin
Morales and Umar Amtiaz. Quickly emerging
victorious on the faculty side was Dr. Zerilli
while Kevin and Umar competed at great
length for the final student spot. The contest
held the crowd on the edge of their seats as the
contestants fired vowels and consonants with
skilled precision. After some time, Umar de-
feated Kevin to advance to the final round
against Dr. Zerilli. Volunteering to go first, Dr. Zerilli had to spell levetiracetam. After a
small mix up of vowels, Umar had his chance to win the event if he was able to spell em-
pagliflozin. Umar spelled empagliflozin correctly and won the event.
All in all, the event was a success with everyone having an enjoyable experience. iGIVE
was able to raise $333 dollars to help pay for medical supplies to send to Guatemala. The
idea for the spelling bee came from Arielle Valenti and Stephanie Cardinale, the students
who attended the mission trip to Guatemala. On behalf of TPN, we would like to extend
our congratulations to the members of iGIVE for their hard work on this event.
Academy of Managed Care Pharmacy Dean’s Hour
with Ms. Edith Rosato
By Deborah Khalou, PharmD Candidate 2016
AMCP Dean’s Hour Organizers
Umar, the champion of the inaugural spelling bee
6
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States, behind heart disease
and cancer. Many patients with COPD often present with multiple-organ dysfunction, especially cardiovascular diseases.
COPD and heart failure (HF) frequently coexist in approximately 30% of cases in clinical practice, and COPD by itself can
be an independent risk factor for developing cardiovascular disease. Beta-blockers are found to be beneficial in reducing
morbidity and mortality in patients with cardiovascular disease, especially HF. However, patients with COPD are often giv-
en a sub-therapeutic dose of a beta-blocker because of the possible effect on airway obstruction, and reduced efficacy of
beta2-agonist and forced expiratory volume in one second (FEV1). Therefore, the management of coexistent COPD and HF
poses a unique therapeutic challenge to health care practitioners.
Historically, beta-blockers have been avoided and considered contraindicated in patients with COPD. Furthermore, many
beta-blockers have prescribing information that warn against use in COPD patients and, if needed, allows clinicians to con-
sider low doses (Table 1). Recent studies have demonstrated that it is considerably safer to use cardio-selective beta-blockers
in COPD patients than previously investigated. However, the selectivity of cardio-selective beta-blockers can be compro-
mised when given in high doses and/or due to drug-drug interactions. Notably, metoprolol succinate and bisoprolol lose
their cardio-selectivity in doses over 100 mg and 20 mg, respectively. Furthermore, patients with COPD and HF often have
other co-morbidities and may require multiple medications to control their symptoms. As a result, these specific patient
populations are prone to multiple drug-drug interactions, which may cause a loss of cardio-selectivity (Table 1). Therefore,
clinicians stray away from using optimal doses of beta-blockers in patients with both COPD and HF.
The Dilemma of Using Beta-Blockers in Patients with Chronic Obstructive Pulmonary Disease and Heart Failure: Time to Shift?
By: Syed Arafath, PharmD Candidate 2015
* Approved for HF
7
Therefore, it is uncertain whether the diminished bronchodi-
lator response and reduced oxygen saturation are clinically
significant and outweigh the benefits of beta-blockers in pa-
tients with HF.
Despite these concerns, COPD patients may often have a
compelling indication to use beta-blockers especially when
they have ischemic heart disease or HF. In a ten-year (2001-
2010) retrospective cohort study of 5977 patients aged >50
years with COPD, Short et al. demonstrated that beta-
blockers have no deleterious effect on lung function. In addi-
tion to cardiovascular benefit from beta-blockers, this study
also showed that beta-blockers reduce mortality (22% reduc-
tion compared to non beta-blocker group; 95% CI: 0.67 to
0.92), COPD exacerbation, and hospitalization when added
to established therapy for COPD. A Cochrane meta-analysis
of 20 studies conducted by Hawkins et al. showed that FEV1
is unaffected by single dose or longer duration of cardio-
selective beta-blockers (-1.8% and -1.26% respectively). Alt-
hough cardio-selective beta-blockers are safe in stable COPD
patients as seen in this study, very little is known about their
effects on patients with deteriorated lung function or acute
respiratory failure. Kargin et al. in a retrospective (2011-2012)
case-control study of 188 patients in an ICU setting showed
that beta-blocker use for heart rate control in COPD patients
with acute respiratory failure have similar ICU lengths of stay
(median: 6 days in case group vs. 7 days in control group) and
mortality (17.6% vs. 15.8%; p = 0.75) compared with COPD
patients treated with other heart rate limiting drugs. Although
all of these studies have suggested that cardio-selective beta-
blockers are relatively safe and do not cause clinically signifi-
cant airway obstruction, COPD exacerbation, or reduction in
quality of life, we need to bear in mind that these are con-
ducted retrospectively for short periods of time. Therefore,
we may need well-designed prospective studies to further
evaluate the benefit of using beta-blockers in HF patients
with COPD.
The American College of Cardiology Foundation/American
Heart Association (ACCF/AHA) guidelines for HF do not
have any specific recommendations regarding patients with
COPD and HF except for cautionary use. In contrast, the
European Society of Cardiology heart failure guidelines pro-
vide a more specific recommendation by stating that beta-
blockers are not contraindicated in patients with COPD and
that cardio-selective beta-blockers could be used in this pa-
tient population. The Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD) guidelines state that the benefit
of using a cardio-selective beta-blocker even in patients with
severe COPD outweighs the risk of bronchospasm. It also
recommends using a beta1-selective beta-blocker, especially
bisoprolol, in COPD patients since bisoprolol was found to
have favorable respiratory parameters such as beneficial ef-
fect on lung function, minimal deleterious effect on COPD
symptoms, and improved quality of life. The ACCF/AHA
also recommends bisoprolol, suggesting a starting dose of
1.25 mg daily and titration up to a maximum of 10 mg daily
for patients with HF. Therefore, based on these guidelines,
bisoprolol could be recommended in patients with concomi-
tant COPD and HF.
The combination of COPD and HF poses a unique challenge
to clinicians. Clinicians need to be aware that bisoprolol loses
its selectivity at 20 mg daily and metoprolol succinate loses se-
lectivity over 100 mg daily. Clinicians also need to monitor
these patients carefully, since drug-drug interactions may cause
beta-blockers to lose their cardio-selectivity. Recent evidence
suggests that using cardio-selective beta-blockers in COPD pa-
tients is not contraindicated, and that they may decrease mor-
tality in patients with concomitant COPD and HF. It is our
duty as pharmacists to make sure that patients with concomi-
tant COPD and HF receive the appropriate beta-blockers at
optimal doses.
NJPhA members at annual national convention
SNPhA Prescription for Health: Dispensing Health Advice
By Emmanuel Aderemi, PharmD Candidate 2016
New FDA Drug Approvals
The FDA is the federal agency re-sponsible for the approval of pre-scription medications and many other healthcare-related products. TPN will feature certain drugs that are in recent news.
Zerbaxa™ - is a new combination antibacterial of ceftolozane (a cephalo-sporin) and tazobactam (a beta-lactamase inhibitor). It was approved on December 19, 2014 as an injection for adults with complicated urinary tract infections including pyelonephritis. It is also used in combination with metronidazole for the treatment of complicated intra-abdominal infections. Zerbaxa™ is marketed by Merck & Co. and is the first new antibiotic approved under the Generating Antibiotic Incen-tives Now (GAIN) Act which provides incentives for the development of new antibacterial agents for serious or life-threatening infections. Rapivab™ (peramavir) – is the first IV neuraminidase inhibitor used to treat influenza in patients 18 years or older who have acute uncomplicated infec-tions and have had flu symptoms for no more than two days. It was devel-oped by BioCryst Pharmaceuticals, Inc. as an injection and approved on De-cember 22, 2014. Blincyto™ (blinatumomab) – is a therapeutic biologic used to treat a rare and rapidly progressing form of acute lymphoblastic leukemia (ALL), known as Philadelphia chromosome-negative precursor B-cell ALL. It was approved on December 3, 2014 as an injection and marketed by Amgen, Inc. Granted breakthrough therapy designation, pri-ority review, and orphan product desig-nation, Blincyto™ underwent acceler-ated approval and is considered a mile-stone in immunotherapy. It is the first single-agent to be approved for this specific condition. Cosentyx™ (secukinumab) – is a ther-apeutic biologic approved on January 21, 2015 for the treatment of moderate-to-severe plaque psoriasis. Available as an injection under the skin, it is intend-ed for patients who are candidates for systemic therapy, phototherapy, or a combination of both.
NJPhA’s Annual Convention
By Muhammad Effendi, PharmD Candi-
date 2016
As any pharmacy student will tell you, it is easy to become consumed by the vast workload
that comes with obtaining a Doctorate in Pharmacy. Despite this, it is imperative that phar-
macy students broaden their horizons by joining and participating in different pharmacy or-
ganizations. New Jersey Pharmacists Association (NJPhA) provides this opportunity to
pharmacy students not only in New Jersey, but also across the tri-state area with chapters at
Long Island University, Rutgers University, Fairleigh Dickinson University, Temple Univer-
sity, and Philadelphia College of Pharmacy. On the weekend of September 20, 2014, NJPhA
hosted their annual convention at the Berkeley Inn, located in Asbury Park, New Jersey.
The day was filled with continuing education programs, networking events, student pro-
grams, and much more. It was truly an incredible experience interacting with other 8
The Student National Pharmaceutical Association (SNPhA)
at LIU is fully dedicated to reaching out to underserved com-
munities in the Bronx, Manhattan, and Brooklyn. Since the
start of the fall semester, SNPhA has been directly involved
in 17 community outreach projects. For SNPhA members, it
goes far beyond just volunteering for another health care
event. We believe that the information we provide can help prevent members in our com-
munity from unknowingly predisposing themselves to chronic diseases. On October 25,
2014, SNPhA’s immunization team organized an event titled “Advocate to Vaccinate.” The
purpose of this event was to educate the
community on the need to vaccinate
against communicable diseases such as
influenza, pneumococcal pneumonia,
and shingles. This event was organized
to honor Polio Day, a day dedicated to
empathize with the areas of the world
where polio has not yet been eradicated.
During the event, the SNPhA immun-
ization team also screened patients for high blood pressure and counseled them on healthy
eating habits using the DASH diet guidelines.
Furthermore, on November 2, 2014, the SNPhA community service team organized an
event titled “Operation: End Diabetes” at a religious center in Queens. We screened pa-
tients for high blood pressure and addressed the need to adopt a lifestyle that reduces the
risk of developing diabetes and hypertension- the two highest risk factors for stroke.
SNPhA members have participated in many similar events and have received positive feed-
back from community members who found these services valuable in maintaining their
health. SNPhA will continue to reach out to underserved communities and not only screen
for risk factors, but also search for opportunities to educate the public on ways to achieve
optimal well-being.
SNPhA members at Operation End Diabetes
On September 27, 2014, the members of The American College of Clinical Pharmacy
(ACCP) at LIU-Pharmacy helped host Drug Take Back Day at Staten Island University
Hospital North Shore-LIJ. We educated patients about the importance of proper disposal
of any old or unwanted medications as well as screened patients’ blood pressures and edu-
cated them on the importance of hypertension and other chronic disease states. The next
day, our organization participated in two events. During the first event, Step Out: Walk to
Stop Diabetes, we educated patients about proper diabetic care. At the second event, The
Tunnels to Towers-NYC, we educated patients and promoted the importance of annual
flu vaccinations.
On October 18, 2014, ACCP collaborated with the American Society of Health-System Pharmacists (ASHP), the American
Pharmacists Association-Academy of Student Pharmacists (APhA), and SNPhA to conduct a community health fair providing
patients with education on the importance of immunizations and several major chronic disease states like hypertension, diabe-
tes, and hyperlipidemia.
Our goal is to continue to provide student members with opportunities to foster their professional growth by learning to apply
their knowledge to help the community.
The Jewish Pharmaceutical Society (JPS) provides professional and cultural guidance as well as networking opportunities
for all students of LIU-Pharmacy and the College of Health Professions. We aim to foster collaboration with all students,
regardless of their religion or other affiliations.
Participants in the health fair
A Bridge Between Culture and Profession
By Debra Willner , PharmD Candidate 2017
9
pharmacy students from other schools, as well as being able to network with highly accomplished and knowledgeable phar-
macists. Those involved in the planning and organization of the annual convention did a great job of exposing the pharmacy
students to several different positive experiences.
The first student program of the day, the Speed Networking Event, was organized by two of LIU’s very own 5th year stu-
dents, Annemarie Mathews and Muhammad Effendi. They invited several highly accomplished and successful pharmacists
representing different areas of pharmacy practice settings ranging from community, industrial, hospital, and long-term care
to participate. It was an incredible experience for the students to be able to interact with the pharmacists on a very personal
level, receive valuable advice, and ask any questions they may have had. The next student event was the NASPA (National
Alliance of State Pharmacy Associations) Student Pharmacist Championship. This was a Jeopardy style game in which 4-5
students from each of the attending schools participated. Representing LIU were Trung Pham, Farhana Sarwar, Ann Siu,
and Muhammad Effendi. The final program of the day was a great opportunity for the student pharmacists to work with
students from other pharmacy schools to create a poster board. Each group worked together to present a board pitching the
services a pharmacist can provide to various health care personnel. Along with the three different student programs were
several other programs one could attend with topics including how to run a business and drug safety in the workplace.
In just one day, NJPhA’s annual convention managed to squeeze in an enormous amount of opportunities, learning experi-
ences, and networking for pharmacy students. There are certain experiences that cannot be emulated through classrooms or
textbooks and NJPhA’s annual convention was exactly that kind of experience.
ACCP Student Chapter’s Campaign to Raise Health
Awareness
By Porfibert Crisantos, PharmD Candidate 2016
On October 18, 2014 APhA arrived at CVS on New Utrecht Avenue in Brooklyn at 10 am and started setting up our
tables outside of the pharmacy. A variety of disease states were represented at the health fair, such as diabetes, hyper-
tension, stroke, hyperlipidemia, osteoporosis, Generation Rx, immunizations, and kidney disease. APhA was responsi-
ble for the hyperlipidemia, osteoporosis, and Generation Rx booths which were accompanied by educational pam-
phlets and posters. All pharmacy students had the chance to educate patients about particular disease states as well as
the opportunity to answer questions about a healthy lifestyle and diet. Also, student pharmacists gave free blood pres-
sure screenings to any health fair attendee. Professor Gonzalez, along with two other pharmacists, Dr. Buscini and Dr.
Elsheemy, supervised
interns and answered
questions from the pa-
tients as well. Overall,
the event was a great
success and was highly
educational for both
attendees and pharma-
cy students. We hope
to continue our collab-
oration with other or-
ganizations for future
events that benefit the
Rho Chi’s Commitment to Academic Excellence
By Wai In Lim, PharmD Candidate 2016
Rho Chi held two Dean's Hours during the Fall 2014 semester. At our first Dean’s Hour, "Special Projects & Research
Opportunities for Pharmacy Students,” guest speakers Dr. Nathan and Dr. Dave discussed opportunities for students that
are provided as an elective. At the end of the elective, students will also have an option to present a poster about their re-
search that they conducted with an LIU-Pharmacy faculty member. The second Dean's Hour was cohosted with ACCP
featuring guest speaker, Maria Sorbera, PharmD PGY2 Ambulatory Care Resident at The Brooklyn Hospital Center. The
purpose of this Dean's Hour was to inform students about preparations for residency, expectations in the ASHP Midyear
Clinical Meeting, and experiences as a resident. Rho Chi participated in the Tunnels to Towers Event with Dr. Shtaynberg
sponsored by Walgreens Pharmacy. We provided blood pressure screenings and spoke to patients about vaccinations. We
currently provide peer tutoring to all pharmacy students every Monday from 5 to 6pm in the pharmacy lounge. We pro-
vide peer tutoring throughout the year. Contact us for further information.
APhA’s Day at the Fair
By Roza Gavrilova, PharmD Candidate 2016
10
Since the start of this academic year, JPS has hosted two successful Dean's Hour events. On October 20, 2014, we orga-
nized a Dean's Hour event which featured Dr. Herbert Sherman, Chair of the Department of Management Sciences of
LIU's School of Business. The topic of the event was "Know your Religious Rights in the Workplace." Topics that were
covered included religious accommodations required by law, religious obligation disclosure during a job inter-
view, and religious garments in the workplace. Students of various religions and professions attended this event. On No-
vember 3, 2014, JPS co-hosted an event with ASHP featuring PGY1 residents from Maimonides Medical Center who
spoke about a day in the life of a pharmacy resident and the residency application process. JPS has many more great ideas
in store for the rest of the year and its officers and members hope to see you at upcoming events!
Health fair participants from various organizations
Something Missing?
If you are reading this and want to write an
article, contact us. If you were searching for
something in this newsletter and didn't find
it, contact us. If you are looking for expo-
sure to a challenging professional writing
experience, contact us. If you have addition-
al questions or concerns about any of the
included articles, contact us. If you are look-
ing for additional ways to get involved in
the school, contact us!
TPN Staff Contact
Information
Editors-in-Chief:
Dexter Wimer, [email protected]
Edwin Lam, [email protected]
Syed Arafath, [email protected]
Social Executive Editors:
Tavajay Campbell
Scientific Executive Editors
Nubriel Hernandez
Ishmam Sarwar, [email protected]
Managing Editor of Health Sciences:
Dominic Regalbuto,
Managing Editor of Pharmacy Practice:
Alise Lingenau, [email protected]
Managing Editor of Pharmaceutical Sciences:
Isha Rana, [email protected]
Managing Editor of Clubs and Organizations:
Hannah Oh, [email protected]
Contact TPN at:
*Article References Furnished upon Request
TPN
A Bit of
Light
Pharmacy
Humor
The Pharmacy Newsletter is currently seeking a motivated indi-
vidual to fill the Managing Editor for Campus News position.
Those interested, please contact us at [email protected]